Hints and tips:
Related Special Reports
...Merck, a healthcare to life sciences group, submitted a takeover offer for JSR in the autumn of 2022, according to the four people familiar with the situation....
...Large pharma companies have warned that a sharp rise in a tax on drug costs, the increase in corporation tax and the difficulty of introducing innovative products into the NHS are all reducing the draw of...
...Several early-stage life sciences investors told the Financial Times the technology was attractive but that the field faced a higher bar for investment than other start-ups....
...Other companies: KKR, Spotify, GE Healthcare, and Hertz are also reporting before the bell. Amgen, Gilead Sciences, Chipotle, Ford and Snap are reporting after the bell....
...Last week, the Danish drugmaker also entered a partnership with GE Healthcare to develop new ways of tackling obesity and diabetes using ultrasound technology....
...The problems of overreliance on broad spectrum antibiotics and a lack of diagnosis are likely to persist in regions without state of the art healthcare, and the resulting resistant superbugs are unlikely...
...British drugmaker GSK also spent $1.4bn on Anglo-American biotech Aiolos Bio to restock its respiratory pipeline. Merck and medical device maker Boston Scientific also announced acquisitions....
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...Currently, the US receives 68 per cent of global biotech investment, according to the industry group Bio, and half of the top 20 biggest spenders on pharma research and development last year were American...
...Months earlier Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company, according to two people with knowledge of its content....
...One we missed: IBM and the Holocaust: The Strategic Alliance Between Nazi Germany and America’s Most Powerful Corporation, by Edwin Black....
...In healthcare, concerns range from data breaches to relying on models trained on data sets that ignore marginalised communities....
...The Covid-19 pandemic put life sciences under a spotlight, accelerating a growing interest in healthcare that was already under way among family offices, says Nooman Haque, a life sciences investor based...
...More healthcare news: The Biden administration has named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs in the US....
...“It’s a big turnround and completely bucking the overall trend in the M&A market,” said Tim Opler, managing director at Stifel’s global healthcare group....
...Letter in response to this article: Healthcare must embrace gene therapy to catch up with science / From Timothy D Hunt, Chief Executive, Alliance for Regenerative Medicine, Washington, DC, US...
...The writer is a science commentator A clown comes knocking on your door with a fun message for your kids. They can have a toy for free — if you buy them a meal from a fast-food restaurant....
...My guest this week is Jason Matheny, president of the Rand Corporation in California....
...Jon Williams, Viridi’s chief executive and a Buffalo native, pays his employees $18 an hour, with healthcare, stock options and a retirement plan included....
...Susan Lee, a partner at the law firm Goodwin who specialises in life sciences regulation, said Kacsmaryk had several options when issuing his ruling....
...“provides comfort for small innovative companies like mine . . . creating jobs, developing new medicines and improving healthcare for patients”....
...Prime minister Rishi Sunak has charged science minister George Freeman with developing an alternative British plan....
...A BMS spokeswoman says: “protection of the intellectual property enables our ability to keep pushing the boundaries of science”....
...In Berkeley, California, a start-up called Pivot Bio, which produces a microbial fertiliser, is enjoying strong demand....
...Ramaswamy founded Roivant Sciences, a SoftBank-backed healthcare company, in 2014....
International Edition